Replies to post #379529 on Anavex Life Sciences Corp (AVXL)

[powerwalker]

Investor, given that the P2b/3 trial in for early AD, don't you think the % of participants on DPZ will be less than the P2a trial, which was mild/moderate AD?

Hopefully, that will be a subset of the in depth analysis: DPZ users vs. non-DPZ users.

ANAVEX NOW ... RIGHT NOW ... MONO-STYLE ... for LIFE ... and for ALL AGES!!!